The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Targeting RIPK1 for the treatment of human diseases
Open accessAbstract
Significance: RIPK1 plays a critical role in mediating deleterious responses downstream of TNFR1. RIPK1 inhibitors have been progressed successfully past human phase I clinical studies. This paper discusses why RIPK1 inhibitors present an opportunity for developing oral drugs for a range of human degenerative and inflammatory diseases, especially CNS pathologies, including ALS, Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, stroke, and lysosomal storage diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · cited 1×
“Similar to the cleavage of GSDMD by caspase-1/4/5/11 which promotes pore formation in pyroptosis (59, 60), RDA may also promote the release of DAMPs via pores formed by GSDMD after its cleavage by caspase-8.”
BackgroundPyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 5×
“A first set of selective necroptosis inhibitors, which we termed necrostatins, was identified using a cell-based screen of TNF-induced necroptosis in a human U937 monocytic cell line (11).”
BackgroundMethodInfluentialSelf-citationMixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · cited 4×
“Ser166 phosphorylation has emerged as a biomarker for RIPK1 activation (12, 21, 22).”
BackgroundInfluentialSelf-citationMan, S. M., Karki, R., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12534 · Cited by 1,657
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Triggering and modulation of apoptosis by oxidative stress
Chandra, J., Samali, A., & Orrenius, S. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00302-6 · Cited by 1,335
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278 · cited 1×
“While caspase-8 in complex with the FLIPL isoform is partially active and this heterodimer can inhibit necroptosis (42), elevated levels of FLIPS may suppress the activation of caspase-8 to promote necroptosis (22).”
BackgroundLi, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 1×
“The amyloid hypothesis is supported by the early onset familial Alzheimer’s disease (FAD) mutations in the amyloid precursor protein (APP) and the presenilin genes that drive amyloidosis (106).”
BackgroundBertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,109
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Self-citationPyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death
Orning, P., Weng, D., Starheim, K., Ratner, D., Best, Z., Lee, B., Brooks, A., Xia, S., Wu, H., Kelliher, M. A., et al. (2018) · Science · doi:10.1126/science.aau2818 · Cited by 1,029
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012 · cited 1×
“However, anti-TNF strategy is not safe for the treatment of CNS diseases due to the involvement of TNFR2 in mediating neural regeneration (14).”
BackgroundHitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989
Self-citationNecroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Self-citationExome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., & Mocarski, E. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462341 · Cited by 959 · cited 1×
“For example, RHIM-domain-dependent activators TRIF and ZBP1 have been shown to engage and activate RIPK3 directly upon TLR3/4 engagement and viral infection (26, 27).”
BackgroundLinear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911
TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains
Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A., Chiu, Y.-H., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 888
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection
Sarhan, J., Liu, B. C., Muendlein, H. I., Li, P., Nilson, R., Tang, A. Y., Rongvaux, A., Bunnell, S. C., Shao, F., Green, D. R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809548115 · Cited by 883
Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 836
MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Dondelinger, Y., Declercq, W., Montessuit, S., Roelandt, R., Goncalves, A., Bruggeman, I., Hulpiau, P., Weber, K., Sehon, C. A., Marquis, R. W., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.026 · Cited by 815
NF-κB Signals Induce the Expression of c-FLIP
Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 813
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt, A., Wieland, T., Richter, B., Ruf, W., Schaeffer, V., Müller, K., Marroquin, N., Nordin, F., Hübers, A., Weydt, P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4000 · Cited by 786
Necroptosis as an alternative form of programmed cell death
Christofferson, D. E., & Yuan, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.003 · Cited by 770
Self-citationUpton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758 · cited 1×
“For example, RHIM-domain-dependent activators TRIF and ZBP1 have been shown to engage and activate RIPK3 directly upon TLR3/4 engagement and viral infection (26, 27).”
BackgroundRegulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
Ofengeim, D., & Yuan, J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3683 · Cited by 621
Self-citationRIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606 · cited 23×
“Interestingly, while TBK1+/− mice are normal, the haploid loss of TAK1, another RIPK1 suppressor, in the myeloid lineage of TBK1+/− mice leads to many of the hallmarks of ALS/FTD, including dysmyelination, axonal degeneration, neuronal loss and cytoplasmic TDP-43 aggregates in the CNS (30).”
BackgroundInfluentialSelf-citationAge-related myelin degradation burdens the clearance function of microglia during aging
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., Edinger, A. L., Jung, S., Rossner, M. J., & Simons, M. (2016) · Nature Neuroscience · doi:10.1038/nn.4325 · Cited by 604
Kang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599 · cited 1×
“which is known to occur before the onset of motor dysfunction (101, 102).”
BackgroundRIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
Rickard, J. A., O’Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., Lawlor, K. E., Ninnis, R. L., Anderton, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.019 · Cited by 593
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Duprez, L., Takahashi, N., Van Hauwermeiren, F., Vandendriessche, B., Goossens, V., Vanden Berghe, T., Declercq, W., Libert, C., Cauwels, A., & Vandenabeele, P. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.020 · Cited by 583
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562 · cited 1×
“This explains the neonatal death of mice deficient in RIPK1; this lethality is reversed by the combined deletion of both caspase-8 and RIPK3 in RIPK1-knockout mice (34, 35).”
BackgroundProgrammed necrosis in inflammation: Toward identification of the effector molecules
Wallach, D., Kang, T.-B., Dillon, C. P., & Green, D. R. (2016) · Science · doi:10.1126/science.aaf2154 · Cited by 544
Activation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.051 · Cited by 526 · cited 8×
“In CNS lesions of both brain samples from MS patients and in mouse models of MS, RIPK1 is relocalized to the insoluble fraction (22), which occurs when RIPK1 is activated (97).”
BackgroundInfluentialSelf-citationCaspase 8 inhibits programmed necrosis by processing CYLD
O’Donnell, M. A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D. R., & Ting, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2362 · Cited by 494
Necroptosis activation in Alzheimer's disease
Caccamo, A., Branca, C., Piras, I. S., Ferreira, E., Huentelman, M. J., Liang, W. S., Readhead, B., Dudley, J. T., Spangenberg, E. E., Green, K. N., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4608 · Cited by 482
Harris, P. A., Berger, S. B., Jeong, J. U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01751 · Cited by 480
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Xu, D., Jin, T., Zhu, H., Chen, H., Ofengeim, D., Zou, C., Mifflin, L., Pan, L., Amin, P., Li, W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.041 · Cited by 461 · cited 9×
“TBK1 knockout mice are embryonically lethal, and this lethality is blocked in TBK1; RIPK1 kinase-dead knock-in mutant mice, which provides a genetic verification for the critical function of TBK1 in regulating the activation of RIPK1 (30).”
BackgroundInfluentialSelf-citationNewton, K., Dugger, D. L., Maltzman, A., Greve, J. M., Hedehus, M., Martin-McNulty, B., Carano, R. A. D., Cao, T. C., van Bruggen, N., Bernstein, L., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.46 · Cited by 438
Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough, P. J., Giansanti, P., Heck, A. J. R., Dejardin, E., Vandenabeele, P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.032 · Cited by 431
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation
Lin, J., Kumari, S., Kim, C., Van, T.-M., Wachsmuth, L., Polykratis, A., & Pasparakis, M. (2016) · Nature · doi:10.1038/nature20558 · Cited by 421 · cited 1×
“ZBP1 deficiency inhibits keratinocyte necroptosis and skin inflammation in epidermis-specific RIPK1 knockout mice (37, 38).”
BackgroundMicroglia and Inflammation in Alzheimers Disease
Mandrekar-Colucci, S., & Landreth, G. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012071 · Cited by 421
Necroptosis in health and diseases
Zhou, W., & Yuan, J. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.07.013 · Cited by 414
Self-citationRIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395
Self-citationRIPK1 inhibits ZBP1-driven necroptosis during development
Newton, K., Wickliffe, K. E., Maltzman, A., Dugger, D. L., Strasser, A., Pham, V. C., Lill, J. R., Roose-Girma, M., Warming, S., Solon, M., et al. (2016) · Nature · doi:10.1038/nature20559 · Cited by 390
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384
Recognizing death: the phagocytosis of apoptotic cells
Platt, N., da Silva, R. P., & Gordon, S. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01329-4 · Cited by 375
Berger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400499 · Cited by 374
Polykratis, A., Hermance, N., Zelic, M., Roderick, J., Kim, C., Van, T.-M., Lee, T. H., Chan, F. K. M., Pasparakis, M., & Kelliher, M. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400590 · Cited by 328
Necrostatin: A Potentially Novel Cardioprotective Agent?
Smith, C. C. T., Davidson, S. M., Lim, S. Y., Simpkin, J. C., Hothersall, J. S., & Yellon, D. M. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6035-1 · Cited by 326
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00406-w · Cited by 325
Self-citationMoquin, D. M., McQuade, T., & Chan, F. K.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076841 · Cited by 320
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
Jaco, I., Annibaldi, A., Lalaoui, N., Wilson, R., Tenev, T., Laurien, L., Kim, C., Jamal, K., Wicky John, S., Liccardi, G., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.003 · Cited by 320
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
Kaiser, W. J., Daley-Bauer, L. P., Thapa, R. J., Mandal, P., Berger, S. B., Huang, C., Sundararajan, A., Guo, H., Roback, L., Speck, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401857111 · Cited by 291 · cited 1×
“The signals leading to activation of RIPK3/caspase-8 in the absence of RIPK1 may originate from the microbiome (36).”
BackgroundRIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
Najjar, M., Saleh, D., Zelic, M., Nogusa, S., Shah, S., Tai, A., Finger, J. N., Polykratis, A., Gough, P. J., Bertin, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.007 · Cited by 284
Self-citationTBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation
Lafont, E., Draber, P., Rieser, E., Reichert, M., Kupka, S., de Miguel, D., Draberova, H., von Mässenhausen, A., Bhamra, A., Henderson, S., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0229-6 · Cited by 283
Harris, P. A., King, B. W., Bandyopadhyay, D., Berger, S. B., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., Finger, J. N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01898 · Cited by 274
You, Z., Savitz, S. I., Yang, J., Degterev, A., Yuan, J., Cuny, G. D., Moskowitz, M. A., & Whalen, M. J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.44 · Cited by 269
Self-citationNeuronal cell death: a demise with different shapes
Nicotera, P., Leist, M., & Manzo, L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01304-8 · Cited by 256
Rosenbaum, D. M., Degterev, A., David, J., Rosenbaum, P. S., Roth, S., Grotta, J. C., Cuny, G. D., Yuan, J., & Savitz, S. I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22314 · Cited by 251
Self-citationStructural Basis of RIP1 Inhibition by Necrostatins
Xie, T., Peng, W., Liu, Y., Yan, C., Maki, J., Degterev, A., Yuan, J., & Shi, Y. (2013) · Structure · doi:10.1016/j.str.2013.01.016 · Cited by 248
Self-citationCuchet-Lourenço, D., Eletto, D., Wu, C., Plagnol, V., Papapietro, O., Curtis, J., Ceron-Gutierrez, L., Bacon, C. M., Hackett, S., Alsaleem, B., et al. (2018) · Science · doi:10.1126/science.aar2641 · Cited by 243
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wang, W., Marinis, J. M., Beal, A. M., Savadkar, S., Wu, Y., Khan, M., Taunk, P. S., Wu, N., Su, W., Wu, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.10.006 · Cited by 242
Iannielli, A., Bido, S., Folladori, L., Segnali, A., Cancellieri, C., Maresca, A., Massimino, L., Rubio, A., Morabito, G., Caporali, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.089 · Cited by 239
Reactive astrocytes undergo M1 microglia/macrohpages-induced necroptosis in spinal cord injury
Fan, H., Zhang, K., Shan, L., Kuang, F., Chen, K., Zhu, K., Ma, H., Ju, G., & Wang, Y.-Z. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0081-8 · Cited by 223
Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression
Zhu, K., Liang, W., Ma, Z., Xu, D., Cao, S., Lu, X., Liu, N., Shan, B., Qian, L., & Yuan, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0524-y · Cited by 217
Self-citationA novel role for RIP1 kinase in mediating TNFα production
Christofferson, D. E., Li, Y., Hitomi, J., Zhou, W., Upperman, C., Zhu, H., Gerber, S. A., Gygi, S., & Yuan, J. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.64 · Cited by 210
Self-citationActivation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
Chiu, I. M., Phatnani, H., Kuligowski, M., Tapia, J. C., Carrasco, M. A., Zhang, M., Maniatis, T., & Carroll, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911405106 · Cited by 194
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
Li, Y., Führer, M., Bahrami, E., Socha, P., Klaudel-Dreszler, M., Bouzidi, A., Liu, Y., Lehle, A. S., Magg, T., Hollizeck, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813582116 · Cited by 194
Caspase inhibitors: viral, cellular and chemical
Callus, B. A., & Vaux, D. L. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402034 · Cited by 191
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
Fauster, A., Rebsamen, M., Huber, K. V. M., Bigenzahn, J. W., Stukalov, A., Lardeau, C.-H., Scorzoni, S., Bruckner, M., Gridling, M., Parapatics, K., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.130 · Cited by 188
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
Peltzer, N., Darding, M., & Walczak, H. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.006 · Cited by 184
RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation
Daniels, B. P., Snyder, A. G., Olsen, T. M., Orozco, S., Oguin, T. H., Tait, S. W. G., Martinez, J., Gale, M., Loo, Y.-M., & Oberst, A. (2017) · Cell · doi:10.1016/j.cell.2017.03.011 · Cited by 177
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
Elliott, P. R., Leske, D., Hrdinka, M., Bagola, K., Fiil, B. K., McLaughlin, S. H., Wagstaff, J. L., Volkmar, N., Christianson, J. C., Kessler, B. M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.001 · Cited by 173
MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis
Liu, S., Liu, H., Johnston, A., Hanna-Addams, S., Reynoso, E., Xiang, Y., & Wang, Z. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707531114 · Cited by 169
The Role of Necroptosis in Cardiovascular Disease
Shi, Z., Li‐Sha, G., & Li, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00721 · Cited by 166
RIPK3 as a potential therapeutic target for Gaucher's disease
Vitner, E. B., Salomon, R., Farfel-Becker, T., Meshcheriakova, A., Ali, M., Klein, A. D., Platt, F. M., Cox, T. M., & Futerman, A. H. (2014) · Nature Medicine · doi:10.1038/nm.3449 · Cited by 164
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Najjar, M., Suebsuwong, C., Ray, S. S., Thapa, R. J., Maki, J. L., Nogusa, S., Shah, S., Saleh, D., Gough, P. J., Bertin, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.052 · Cited by 163
Self-citationThe Structural Basis of Necroptotic Cell Death Signaling
Petrie, E. J., Czabotar, P. E., & Murphy, J. M. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.002 · Cited by 163
Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
Annibaldi, A., John, S. W., Berghe, T. V., Swatek, K. N., Ruan, J., Liccardi, G., Bianchi, K., Elliott, P. R., Choi, S. M., Coillie, S. V., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.027 · Cited by 162
Alarmins, inflammasomes and immunity
Ojcius, D., & Saïd-Sadier, N. (2012) · Biomedical Journal · doi:10.4103/2319-4170.104408 · Cited by 161
Meng, H., Liu, Z., Li, X., Wang, H., Jin, T., Wu, G., Shan, B., Christofferson, D. E., Qi, C., Yu, Q., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722013115 · Cited by 161
Self-citationRIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3
Lukens, J. R., Vogel, P., Johnson, G. R., Kelliher, M. A., Iwakura, Y., Lamkanfi, M., & Kanneganti, T.-D. (2013) · Nature · doi:10.1038/nature12174 · Cited by 158
Amin, P. P., Florez, M. A., Najafov, A., Pan, H., Geng, J., Ofengeim, D., Dziedzic, S. A., Wang, H., Barrett, V. J., Ito, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806973115 · Cited by 158
Self-citationCaspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia
Kim, S. J., & Li, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.238 · Cited by 157
Weisel, K., Scott, N. E., Tompson, D. J., Votta, B. J., Madhavan, S., Povey, K., Wolstenholme, A., Simeoni, M., Rudo, T. J., Richards‐Peterson, L. E., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.365 · Cited by 150
Collins, J. S., Perry, R. T., Watson, B., Harrell, L. E., Acton, R. T., Blacker, D., Albert, M., Tanzi, R. E., Bassett, S. S., McInnis, M. G., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001204)96:6<823::aid-ajmg26>3.0.co;2-i · Cited by 139
SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
Kupka, S., De Miguel, D., Draber, P., Martino, L., Surinova, S., Rittinger, K., & Walczak, H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.086 · Cited by 135
Yoshikawa, M., Saitoh, M., Katoh, T., Seki, T., Bigi-Botterill, S. V., Shimizu, Y., Ishii, T., Okai, T., Kuno, M., Hattori, H., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01647 · Cited by 131
Wang, H., Meng, H., Li, X., Zhu, K., Dong, K., Mookhtiar, A. K., Wei, H., Li, Y., Sun, S., & Yuan, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715742114 · Cited by 130
Self-citationElevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death
Garcia‐Carbonell, R., Wong, J., Kim, J. Y., Close, L. A., Boland, B. S., Wong, T. L., Harris, P. A., Ho, S. B., Das, S., Ernst, P. B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810584115 · Cited by 125
Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
Pegoretti, V., Baron, W., Laman, J. D., & Eisel, U. L. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00925 · Cited by 117
Divinations and Surprises: Genetic Analysis of Caspase Function in Mice
Zheng, T. S., & Flavell, R. A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4841 · Cited by 113
Dziedzic, S. A., Su, Z., Barrett, V. J., Najafov, A., Mookhtiar, A. K., Amin, P. P., Pan, H., Sun, L., Zhu, H., Ma, A. I., et al. (2017) · Nature Cell Biology · doi:10.1038/s41556-017-0003-1 · Cited by 103
Self-citationLUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Taraborrelli, L., Peltzer, N., Montinaro, A., Kupka, S., Rieser, E., Hartwig, T., Sarr, A., Darding, M., Dráber, P., Haas, T. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06155-8 · Cited by 103
Dvoriantchikova, G., Degterev, A., & Ivanov, D. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.009 · Cited by 99
Self-citationMicroglial activation occurs late during preclinical Alzheimer's disease
Streit, W. J., Braak, H., Del Tredici, K., Leyh, J., Lier, J., Khoshbouei, H., Eisenlöffel, C., Müller, W., & Bechmann, I. (2018) · Glia · doi:10.1002/glia.23510 · Cited by 98
Ni, Y., Gu, W.-W., Liu, Z.-H., Zhu, Y.-M., Rong, J., Kent, T. A., Li, M., Qiao, S.-G., An, J.-Z., & Zhang, H.-L. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.038 · Cited by 87
Liu, T., Zhao, D.-X., Cui, H., Chen, L., Bao, Y., Wang, Y., & Jiang, J. (2016) · Scientific Reports · doi:10.1038/srep24547 · Cited by 85
Phenytoin inhibits necroptosis
von Mäßenhausen, A., Tonnus, W., Himmerkus, N., Parmentier, S. P., Saleh, D., Rodríguez, D. A., Ousingsawat, J., Ang, R. L., Weinberg, J. M., Sanz, A. B., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0394-3 · Cited by 77
Self-citationAkt Regulates TNFα Synthesis Downstream of RIP1 Kinase Activation during Necroptosis
McNamara, C. R., Ahuja, R., Osafo-Addo, A. D., Barrows, D., Kettenbach, A. N., Skidan, I. N., Teng, X., Cuny, G. D., Gerber, S. A., & Degterev, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056576 · Cited by 75
Self-citationShutinoski, B., Alturki, N. A., Rijal, D., Bertin, J., Gough, P. J., Schlossmacher, M. G., & Sad, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.51 · Cited by 75
RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
Martens, S., Goossens, V., Devisscher, L., Hofmans, S., Claeys, P., Vuylsteke, M., Takahashi, N., Augustyns, K., & Vandenabeele, P. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0245-7 · Cited by 74
Ma, J., Tanaka, K. F., Shimizu, T., Bernard, C. C. A., Kakita, A., Takahashi, H., Pfeiffer, S. E., & Ikenaka, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22567 · Cited by 69
Role of necroptosis in autophagy signaling during hepatic ischemia and reperfusion
Hong, J., Kim, S., & Lee, S. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.010 · Cited by 69
Chen, Y., Zhang, L., Yu, H., Song, K., Shi, J., Chen, L., & Cheng, J. G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.007 · Cited by 69
Ischemia Reperfusion Injury Triggers TNFα Induced-Necroptosis in Rat Retina
Kim, C. R., Kim, J., Park, H.-Y. L., & Park, C. K. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1227449 · Cited by 62
Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide
Saleh, D., Najjar, M., Zelic, M., Shah, S., Nogusa, S., Polykratis, A., Paczosa, M. K., Gough, P. J., Bertin, J., Whalen, M. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601717 · Cited by 59
Self-citationCaspase-8, association with Alzheimer’s Disease and functional analysis of rare variants
Rehker, J., Rodhe, J., Nesbitt, R., Boyle, E. A., Martin, B., Lord, J., Karaca, I., Naj, A. C., Jessen, F., Helisalmi, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185777 · Cited by 53
Papassotiropoulos, A., Lambert, J.-C., Wavrant-De Vrièze, F., Wollmer, M. A., von der Kammer, H., Streffer, J. R., Maddalena, A., Huynh, K.-D., Wolleb, S., Lütjohann, D., et al. (2005) · Neurodegenerative Diseases · doi:10.1159/000090362 · Cited by 51
Zhang, S., Wang, Y., Li, D., Wu, J., Si, W., & Wu, Y. (2016) · Medicines · doi:10.3390/medicines3030016 · Cited by 43
RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient mice
Liu, Y., Fan, C., Zhang, Y., Yu, X., Wu, X., Zhang, X., Zhao, Q., Zhang, H., Xie, Q., Li, M., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.78 · Cited by 42
Kang, T., Jeong, J.-S., Yang, S., Kovalenko, A., & Wallach, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0104-9 · Cited by 40
Cougnoux, A., Clifford, S., Salman, A., Ng, S. L., Bertin, J., & Porter, F. D. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.10.009 · Cited by 30
Cystatin F is a biomarker of prion pathogenesis in mice
Nuvolone, M., Schmid, N., Miele, G., Sorce, S., Moos, R., Schori, C., Beerli, R. R., Bauer, M., Saudan, P., Dietmeier, K., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171923 · Cited by 25
Cited by
Trends in kinase drug discovery: targets, indications and inhibitor design
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 779
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 728
Wang, Y., & Kanneganti, T.-D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.038 · Cited by 545
“For example, although the cause of neuronal cell loss during ischemic and neurodegenerative disease is still mysterious [155], the inflammasome [156], CASP8 [157] and RIPK1 [158,159], core components of the PANoptosome, are implicated in neuronal death [155].”
BackgroundThe different autophagy degradation pathways and neurodegeneration
Fleming, A., Bourdenx, M., Fujimaki, M., Karabiyik, C., Krause, G. J., Lopez, A., Martín-Segura, A., Puri, C., Scrivo, A., Skidmore, J., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.017 · Cited by 480
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 479
Self-citation
Metadata
- Authors
- Degterev, A., Ofengeim, D., & Yuan, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-05-02
- Volume
- 116
- Issue
- 20
- Pages
- 9714-9722
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2942761172
- Cited by
- 408
- References
- 124
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- HHS | NIH | National Institute on Aging (1R01AG047231)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.